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OBJECTIVE: In 2002, Maine’s Tobacco HelpLine began offer-
ing free nicotine replacement therapy (NRT), including patch
and/or gum, to adult smokers who were uninsured without NRT
beneﬁts. A study was conducted in 2005 to assess knowledge,
utilization patterns, short-term outcomes, and satisfaction
among a sample of Maine Tobacco HelpLine callers who re-
ceived this free NRT from any Maine pharmacy. METHODS:
Telephone surveys were conducted in June-July 2005 among 541
eligible HelpLine callers authorized for NRT between February-
March 2005. There were 393 completed interviews, for a 73%
response rate. Descriptive analyses and Chi-Square tests were
conducted using SPSS and SAS, including tests for signiﬁcant
differences by demographic variables and NRT utilization pat-
terns. RESULTS: Half of study respondents were aware of avail-
able free NRT prior to calling the HelpLine, and among them
95% indicated that NRT at least somewhat inﬂuenced their
decision to contact the HelpLine. Most callers were very satisﬁed
(88%) and reported that this process was ‘very helpful’ in their
quit attempt (66%). Almost all respondents picked up NRT
(99%), had no problems obtaining it (91%), and quit for at least
24 hours since calling the HelpLine (92%). Among those who
quit for at least 24 hours, 95% used NRT; but, 28% reported
stopping and starting NRT use and almost 40% reported side
effects, most commonly skin reactions or abnormal dreams. Chi-
square tests reported a signiﬁcant difference in side effects by age,
with more side effects among younger respondents. When sur-
veyed, 50% of respondents reported abstinence from smoking,
which signiﬁcantly differed by NRT duration; smoking during
NRT use; and timing of NRT use. CONCLUSION: Providing
free NRT through this state-supported program encouraged
smokers to contact the Maine Tobacco HelpLine and use avail-
able NRT, demonstrating a valuable opportunity for quit lines to
provide NRT access and increase demand among motivated
smokers.
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OBJECTIVE: The purpose of this paper is to take an analytical
view of the diagnosis and procedures that most frequently occur
with Chronic Obstructive Pulmonary Disease (COPD) patients
when they are admitted to the hospital. METHODS: The data
was collected from the National Inpatient Sample (NIS); they
were analyzed using the SAS Program Enterprise Guide 4. The
data were from over 32,000 patients that were diagnosed with
some type of COPD using a 10% sample from 2004. Some of the
variables examined were: the age, the length of stay, mortality
rates, total charges, and the diagnostic, and procedure codes for
the patients. In analyzing the data, codes were compressed to
ﬁlter the top 20 principle diagnosis codes, the top 20 procedure
codes, and the top twenty DRG codes. RESULTS: The results of
the data analysis show that there are many different principal
diagnoses, procedures, and DRG’s used when patients come to
the hospital with COPD. The highest principal diagnosis is
COPD and bronchiectasis, the top procedure is classiﬁed as other
vascular catheterization, and the top DRG in effect on the dis-
charge date is COPD. The results also show that 5% of the
patients died while they were in the hospital. The total charges
for the patients show that the majority of the patients’ total
charges were less than $10,000. Logistic regression showed that
mortality is directly related to these diagnostic and procedure
codes. CONCLUSION: More research on COPD is necessary.
COPD is the fourth leading cause of death in the US, but there is
virtually no research on the disease. The analysis of this dataset
shows that the knowledge of this disease is limited and more
research must be conducted.
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OBJECTIVE: Although antihistamines do not have an on-label
indication for asthma, previous study showed increased prescrib-
ing in asthma by physicians. This study examined patient and
physician predictors of obtaining an antihistamine for asthma in
the absence of allergic diseases in 2005. METHODS: Ofﬁce-
based physician visits or outpatient visits by patients with asthma
were selected from the 2005 National Ambulatory Medical Care
Survey and the National Hospital Ambulatory Medical Care
Survey. Asthma was deﬁned by either a diagnosis code of asthma
(ICD-9-CM: 493.xx), a reason-for-visit code of asthma (2625.0),
or afﬁrmative answer to a question asking if patients have asthma
irrespective of the diagnosis. Visits with concomitant allergic
diseases indicated for antihistamines were excluded. The study
applied multivariate logistic regression analysis in Stata 9 to take
into account of the complex survey design. RESULTS: In 2005,
11% of the 54.3 millions asthma visits had an antihistamine
prescribed. During ofﬁce-based physician visits, females (OR:
1.25; 95%-CI: 1.07–2.02), patients prescribed leukotriene recep-
tor antagonists (LRTA) (OR: 2.94; 95%-CI: 1.33–6.50), or short
acting beta agonists (SABA) (OR: 2.37; 95%-CI: 1.24–4.53),
were more likely to receive an antihistamine prescription. Physi-
cians in Metropolitan Status Area (MSA) (OR: 2.23; 95%-CI:
1.03- 4.85) were more likely to prescribe antihistamine in
asthma. But those with access to electronic medical records
(EMR) (OR: 0.36; CI: 0.15–0.88) were less likely to do so. Only
LRTA (OR: 5.27; 95%-CI: 2.49–11.12), MSA (OR 9.01; 95%-
CI: 2.13–38.03) and EMR (OR: 0.27; 95%-CI: 0.08–0.88) were
signiﬁcant predictors for antihistamine prescribing in outpatient
department. However, asthma patients treated by their primary
care physicians were more likely to receive an antihistamine (OR:
2.9; 95%-CI: 1.45–5.80). CONCLUSION: Signiﬁcant disparities
in patient and physician characteristics were identiﬁed for
antihistamine prescribing in asthma. Results also indicate that
antihistamines were used as a complement for long-term asthma
management.
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OBJECTIVE: Medication possession ratios (MPRs) can be mis-
leading as an indicator of adherence, especially where several
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